| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 21, 2024 | Brain Cancer Cure? Elon Musk reveals WELIREG, the hidden cancer pill that passed Harvard trials and saved his friend’s mom’s life | According to the American Brain Tumor Association, approximately 90,000 people are diagnosed with a primary brain tumor each year, making brain and other central nervous system (CNS) tumors the fifth most common form of cancer. With over 1 ... |
| Jan 11, 2024 | Michael Strahan's daughter developed headaches when she started at college. They turned out to be symptoms of a fast-growing brain tumor | Health Michael Strahan's daughter developed headaches when she started at college. They turned out to be symptoms of a fast-growing brain tumor
Kim Schewitz
2024-01-11T16:16:39Z
Share icon An curved arrow pointing right.
Share
Facebook Icon... |
| Jan 5, 2023 | Be Aggressive With Initial Brain Tumor Surgery to Boost Survival: Study | THURSDAY, Jan. 5, 2023 (HealthDay News) – Researchers studying patients with low-grade, slow-growing brain tumors have found that more aggressive surgery may extend survival.
The trick to treating low-grade gliomas is to remove as much of t... |
| Aug 24, 2021 | Survey Finds Disparities In Care Of Patients with Metastatic Brain Tumors | |
| May 17, 2021 | ICAD, INC.
ICAD : Announces Educational Webinar Featuring Leading Global Experts Discussing New Multidisciplinary Approach for Treating Brain Tumors, May 25 | NASHUA, N.H., May 17, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced a virtual roundtable discussion will feature leading e... |
| Jan 28, 2021 | American Brain Tumor Association Announces New Board of Directors Chair and Members | |
| Nov 23, 2020 | Edelman’s Shark Tank For Good Event Scores Wins For All Involved | When global marketing and PR firm Edelman launched its Shark Tank for Good event in New York City last January to support local organizations in the nonprofit and not-for-profit sectors, like the whole world, they didn’t know the impact 202... |
| May 11, 2020 | Intel partners with Penn Medicine to develop brain tumor classifier with federated learning | To coincide with Brain Tumor Awareness Month, Intel today announced the details of a National Institutes of Health-funded program that will leverage AI to identify brain tumors while preserving privacy. Together with the Perelman School of ... |
| May 11, 2020 | Intel and Penn Medicine Partnering to Develop an A.I. That Can Discover Brain Tumors | Nhx Tingson, Tech Times 11 May 2020, 01:05 pm
Researchers from Intel Labs and the Perelman School of Medicine at the University of Pennsylvania (Penn Medicine) are cooperating to create a new Artificial Intelligence or AI model that can spo... |
| May 11, 2020 | Intel partners with Penn Medicine to develop brain tumor classifier with federated learning | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
To coincide with Brain Tumor Awareness Month, Int... |
| Apr 18, 2018 | CNS Pharma tries new therapeutic, financing approaches against glioblastoma | “You do temozolomide and radiation to shrink the tumor, and then you do surgery, and then you radiate the rest of the tumor, giving temozolomide,” said CNS Pharma’s CMO Sandra Silberman in a phone interview. “Then you just wait for the tumo... |
| Jul 21, 2017 | Can the immunotherapy movement march into glioblastomas? | Brain cancers are always a challenge to treat, noted Jeffrey Bacha, cofounder and CEO of DelMar Pharmaceuticals, which has an investigational GBM drug in Phase 3 trials.
“Unfortunately, there have been no real drug approvals in the field of... |
| Jul 20, 2016 | A Q&A with CEO of Oncorus that just raised $57M to battle cancer | The Cambridge, Massachusetts, startup launched on Tuesday announcing that it has raised $57 million in a Series A funding round. Oncorus aims to develop a next-generation immunotherapy platform of oncolytic viruses to treat various kinds of... |
| May 29, 2014 | New brain cancer treatment targets tumor hypoxia to make radiation therapy work better | Patients diagnosed with large hypoxic tumors often have only several months to live. Hypoxia in GB is to blame for poor treatment responses to the standard of care radiotherapy/chemotherapy that rely on oxygen to be effective. Hypoxia also ... |
| Mar 19, 2014 | In Watson’s latest healthcare technology news, it takes on personalized brain tumor treatment | In a healthcare technology news development, a new prototype of Watson will be used to analyze genetic data along with drug databases and biomedical journal articles. Watson learns as it processes new information, so the goal is to increase... |
| Aug 17, 2012 | Brain cancer therapy that kills tumor cells with an adenovirus heads for phase 2 trial | Initially, the drug is being studied in high-grade gliomas, brain tumors that are rarely curable even with surgery, radiation and chemotherapy.
Tufaro said the company saw “tremendous efficacy” in its phase 1 study conducted at MD Anderson ... |
| Jul 20, 2007 | Own A Piece Of Reddit, Help Cure Cancer | Reddit co-founders, Steve Huffman and Alexis Ohanian, sold their company to Conde Nast at the end of last year. Now they’re planning giving their laptops a liquidity event.
They’re placing the two Apple G4 Powerbooks (12″ and 15″) used to s... |
| CNS Pharma tries new therapeutic, financing approaches against glioblastoma | Houston-based CNS Pharmaceuticals is combining an unusual financing method with some interesting chemistry to expand the therapeutic choices for glioblastoma patients. The company is using crowdfunding to bridge the gap between an early fri... |
| In Watson’s latest healthcare technology news, it takes on personalized brain tumor treatment | Watson is turning into quite the oncology expert. In its latest healthcare technology news, the computer platform is being used as part of a collaboration between IBM and New York Genome Center. Glioblastomas, an aggressive, frequently mali... |
| New brain cancer treatment targets tumor hypoxia to make radiation therapy work better | Omniox, Inc. is a biopharmaceutical company with a new protein-based platform (H-NOX) that has been engineered to make radiation therapy more effective for certain brain tumors.
The lead H-NOX product (OMX-4.80) is being developed in partne... |
| A Q&A with CEO of Oncorus that just raised $57M to battle cancer | The field of immuno-oncology is exciting for investors, patients and physicians, with a daily drum beat of new efforts being undertaken to battle cancer.
Add Oncorus to that growing chorus.
The Cambridge, Massachusetts, startup launched on ... |
| Can the immunotherapy movement march into glioblastomas? | Sen. John McCain leaves a meeting of GOP senators in the U.S. Capitol June 22, 2017.
On Wednesday, Mayo Clinic released a statement revealing that longstanding Republican Senator John McCain has an aggressive form of brain cancer.
Called gl... |
| Brain cancer therapy that kills tumor cells with an adenovirus heads for phase 2 trial | After seeing “tremendous efficacy” in a phase 1 study, a cancer drug firm is preparing for what it thinks will be a phase 2 pivotal study early next year of its virus therapy for brain tumors.
DNAtrix Inc.’s technology is an oncolytic agent... |